Chromogenic Factor VIII Inhibitor Bethesda Profile
Synonyms |
|
||||||||||||||||||||
Cerner Name |
|||||||||||||||||||||
Clinical Info |
Detecting the presence and titer of a specific factor inhibitor directed againstcoagulation factor VIII for patients on emicizumab (Hemlibra) Detecting the presence and titer of an inhibitor directed against factor VIII This test is not useful for detecting the presence of inhibitors directed against other clotting factors and will not detect the presence of lupus anticoagulants. |
||||||||||||||||||||
Specimen Sources |
Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous |
||||||||||||||||||||
Specimen Types |
Blood |
||||||||||||||||||||
Specimen Volume |
|||||||||||||||||||||
Container |
Light Blue Top Tube |
||||||||||||||||||||
Collection Instructions |
Container Tube: Light Blue Top Tube |
||||||||||||||||||||
Transport Instructions |
Frozen |
||||||||||||||||||||
Specimen Stability |
14 Days Frozen |
||||||||||||||||||||
Methodology |
Chromogenic |
||||||||||||||||||||
Days Performed |
TAT: 3-5 Days |
||||||||||||||||||||
Performing Laboratory |
Mayo Medical Laboratories |
||||||||||||||||||||
CPT |
85130 |
||||||||||||||||||||
PDM |
245700 |
||||||||||||||||||||
Only Orderable at Locations: |
Orderable Everywhere |
||||||||||||||||||||
Results |
|
||||||||||||||||||||
Result InterpretationCHROMOGENIC Factor VIII Activity Assay Adults: 55.0-200.0% Normal, full-term newborn infants or healthy premature infants usually have normal or elevated factor VIII. BETHESDA TITER < or =0.5 Bethesda Units |
|||||||||||||||||||||
Forms |
|